• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类HLA - I类分子的自然杀伤细胞受体。Kp43(CD94)分子作为HLA - B等位基因受体的证据。

Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles.

作者信息

Moretta A, Vitale M, Sivori S, Bottino C, Morelli L, Augugliaro R, Barbaresi M, Pende D, Ciccone E, Lopez-Botet M, Moretta L

机构信息

Istituto di Istologia ed Embriologia Generale, Università di Genova, Italy.

出版信息

J Exp Med. 1994 Aug 1;180(2):545-55. doi: 10.1084/jem.180.2.545.

DOI:10.1084/jem.180.2.545
PMID:8046333
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2191622/
Abstract

GL183 or EB6 (p58) molecules have been shown to function as receptors for different HLA-C alleles and to deliver an inhibitory signal to natural killer (NK) cells, thus preventing lysis of target cells. In this study, we analyzed a subset of NK cells characterized by a p58-negative surface phenotype. We show that p58-negative clones, although specific for class I molecules do not recognize HLA-C alleles. In addition, by the use of appropriate target cells transfected with different HLA-class I alleles we identified HLA-B7 as the protective element recognized by a fraction of p58-negative clones. In an attempt to identify the receptor molecules expressed by HLA-B7-specific clones, monoclonal antibodies (mAbs) were selected after mice immunization with such clones. Two of these mAbs, termed XA-88 and XA-185, and their F(ab')2 fragments, were found to reconstitute lysis of B7+ target cells by B7-specific NK clones. Both mAbs were shown to be directed against the recently clustered Kp43 molecule (CD94). Thus, mAb-mediated masking of Kp43 molecules interferes with recognition of HLA-B7 and results in target cell lysis. Moreover, in a redirected killing assay, the cross-linking of Kp43 molecules mediated by the XA185 mAb strongly inhibited the cytolytic activity of HLA-B7-specific NK clones, thus mimicking the functional effect of B7 molecules. Taken together, these data strongly suggest that Kp43 molecules function as receptors for HLA-B7 and that this receptor/ligand interaction results in inhibition of the NK-mediated cytolytic activity. Indirect immunofluorescence and FACS analysis of a large number of random NK clones showed that Kp43 molecules (a) were brightly expressed on a subset of p58-negative clones, corresponding to those specific for HLA-B7; (b) displayed a medium/low fluorescence in the p58-negative clones that are not B7-specific as well as in most p58+ NK clones; and (c) were brightly expressed as in the p58+ clone ET34 (GL183-/EB6+, Cw4-specific). Functional analysis revealed that Kp43 functioned as an inhibitory receptor only in NK clones displaying bright fluorescence. These studies also indicate that some NK clones (e.g., the ET34) can coexpress two distinct receptors (p58 and Kp43) for different class I alleles (Cw4 and B7). Finally, we show that Kp43 molecules function as receptors only for some HLA-B alleles and that still undefined receptor(s) must exist for other HLA-B alleles including B27.

摘要

GL183或EB6(p58)分子已被证明可作为不同HLA - C等位基因的受体,并向自然杀伤(NK)细胞传递抑制信号,从而防止靶细胞裂解。在本研究中,我们分析了一组具有p58阴性表面表型的NK细胞亚群。我们发现,p58阴性克隆虽然对I类分子具有特异性,但不识别HLA - C等位基因。此外,通过使用转染了不同HLA - I类等位基因的合适靶细胞,我们确定HLA - B7是一部分p58阴性克隆所识别的保护元件。为了鉴定由HLA - B7特异性克隆表达的受体分子,在用此类克隆免疫小鼠后选择了单克隆抗体(mAb)。发现其中两种单克隆抗体,称为XA - 88和XA - 185,及其F(ab')2片段,可重建B7特异性NK克隆对B7 +靶细胞的裂解作用。这两种单克隆抗体均显示针对最近聚类的Kp43分子(CD94)。因此,mAb介导的Kp43分子掩盖会干扰对HLA - B7的识别并导致靶细胞裂解。此外,在重定向杀伤试验中,XA185单克隆抗体介导的Kp43分子交联强烈抑制了HLA - B7特异性NK克隆的细胞溶解活性,从而模拟了B7分子的功能效应。综上所述这些数据强烈表明,Kp43分子作为HLA - B7的受体,并且这种受体/配体相互作用导致NK介导的细胞溶解活性受到抑制。对大量随机NK克隆进行间接免疫荧光和FACS分析表明,Kp43分子:(a)在一部分p58阴性克隆上高表达,这些克隆对应于对HLA - B7具有特异性的克隆;(b)在非B7特异性的p58阴性克隆以及大多数p58 + NK克隆中显示中/低荧光;(c)与p58 +克隆ET34(GL183 - /EB6 +,Cw4特异性)一样高表达。功能分析表明,Kp43仅在显示高荧光的NK克隆中作为抑制性受体起作用。这些研究还表明,一些NK克隆(例如ET34)可以共表达针对不同I类等位基因(Cw4和B7)的两种不同受体(p58和Kp43)。最后,我们表明Kp43分子仅作为某些HLA - B等位基因的受体,而对于包括B27在内的其他HLA - B等位基因,必定存在尚未确定的受体。

相似文献

1
Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles.人类HLA - I类分子的自然杀伤细胞受体。Kp43(CD94)分子作为HLA - B等位基因受体的证据。
J Exp Med. 1994 Aug 1;180(2):545-55. doi: 10.1084/jem.180.2.545.
2
P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities.P58分子作为人类自然杀伤(NK)细胞中主要组织相容性复合体(MHC)I类分子的假定受体。抗p58抗体可重建在具有不同特异性的NK克隆中对MHC I类保护细胞的杀伤作用。
J Exp Med. 1993 Aug 1;178(2):597-604. doi: 10.1084/jem.178.2.597.
3
Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.人类自然杀伤细胞中存在针对HLA - C分子的抑制性(p58)和激活性(p50)受体。
J Exp Med. 1995 Sep 1;182(3):875-84. doi: 10.1084/jem.182.3.875.
4
Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production.具有自然杀伤(NK)样活性的细胞毒性T淋巴细胞:HLA I类分子(p58和CD94)的NK相关功能受体的表达及其对TCR介导的靶细胞裂解或淋巴因子产生的抑制作用。
Int Immunol. 1995 Apr;7(4):697-703. doi: 10.1093/intimm/7.4.697.
5
HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.人类自然杀伤细胞对HLA - G的识别。CD94作为抑制性和激活性受体复合物的参与情况。
Eur J Immunol. 1997 Aug;27(8):1875-80. doi: 10.1002/eji.1830270809.
6
The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase.人类主要组织相容性复合体I类分子的自然杀伤细胞受体。p58分子的表面调节及其与CD3ζ链、FcεRIγ链和p56lck激酶的联系。
Eur J Immunol. 1994 Oct;24(10):2527-34. doi: 10.1002/eji.1830241040.
7
General role of HLA class I molecules in the protection of target cells from lysis by natural killer cells: evidence that the free heavy chains of class I molecules are not sufficient to mediate the protective effect.HLA I类分子在保护靶细胞免受自然杀伤细胞裂解中的一般作用:I类分子的游离重链不足以介导保护作用的证据。
Int Immunol. 1995 Mar;7(3):393-400. doi: 10.1093/intimm/7.3.393.
8
Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.通过克隆性分布的功能性表面分子表达鉴定人类CD3-CD16+自然杀伤(NK)细胞的四个亚群:NK克隆的亚群分配与介导特异性同种异体抗原识别能力之间的相关性。
J Exp Med. 1990 Dec 1;172(6):1589-98. doi: 10.1084/jem.172.6.1589.
9
CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies.CD94作为针对不同HLA I类等位基因的自然杀伤细胞抑制性受体:利用新型单克隆抗体鉴定CD94的抑制形式。
Eur J Immunol. 1996 Oct;26(10):2487-92. doi: 10.1002/eji.1830261032.
10
Coexpression of two functionally independent p58 inhibitory receptors in human natural killer cell clones results in the inability to kill all normal allogeneic target cells.在人类自然杀伤细胞克隆中,两种功能独立的p58抑制性受体的共表达导致无法杀伤所有正常的异基因靶细胞。
Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3536-40. doi: 10.1073/pnas.92.8.3536.

引用本文的文献

1
CD94-driven expansion of highly functional adaptive NKG2C NKG2A CD57 NK cells from CMV healthy donors.来自巨细胞病毒健康供体的由CD94驱动的高功能适应性NKG2C NKG2A CD57 NK细胞的扩增。
Front Immunol. 2025 Jan 31;16:1481745. doi: 10.3389/fimmu.2025.1481745. eCollection 2025.
2
Progressive natural killer cell dysfunction in advanced-stage clear-cell renal cell carcinoma and association with clinical outcomes.晚期透明细胞肾细胞癌中自然杀伤细胞功能的进行性障碍及其与临床结局的关联
ESMO Open. 2025 Feb;10(2):104105. doi: 10.1016/j.esmoop.2024.104105. Epub 2025 Jan 14.
3
Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer.人类自然杀伤细胞中的抑制性受体和检查点及其在癌症免疫治疗中的意义。
Front Immunol. 2020 Sep 3;11:2156. doi: 10.3389/fimmu.2020.02156. eCollection 2020.
4
Harnessing NK Cell Checkpoint-Modulating Immunotherapies.利用自然杀伤细胞检查点调节免疫疗法。
Cancers (Basel). 2020 Jul 6;12(7):1807. doi: 10.3390/cancers12071807.
5
Innate Immune Responses in the Outcome of Haploidentical Hematopoietic Stem Cell Transplantation to Cure Hematologic Malignancies.固有免疫反应在单倍体造血干细胞移植治疗血液系统恶性肿瘤中的作用。
Front Immunol. 2019 Nov 28;10:2794. doi: 10.3389/fimmu.2019.02794. eCollection 2019.
6
Alessandro Moretta and Transporter Associated With Antigen Processing (TAP) Deficiency: On Giant's Shoulders.Alessandro Moretta 和抗原加工相关转运体(TAP)缺陷:巨人的肩膀上。
Front Immunol. 2019 Oct 15;10:2404. doi: 10.3389/fimmu.2019.02404. eCollection 2019.
7
Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation.杀伤细胞免疫球蛋白样受体(KIRs):其在 NK 细胞调节中的作用及导致其临床应用的发展。
Front Immunol. 2019 May 28;10:1179. doi: 10.3389/fimmu.2019.01179. eCollection 2019.
8
Enhancing Natural Killer and CD8 T Cell-Mediated Anticancer Cytotoxicity and Proliferation of CD8 T Cells with HLA-E Monospecific Monoclonal Antibodies.利用HLA-E单特异性单克隆抗体增强自然杀伤细胞和CD8 T细胞介导的抗癌细胞毒性以及CD8 T细胞的增殖
Monoclon Antib Immunodiagn Immunother. 2019 Apr;38(2):38-59. doi: 10.1089/mab.2018.0043.
9
Immune selection during tumor checkpoint inhibition therapy paves way for NK-cell "missing self" recognition.肿瘤检查点抑制疗法期间的免疫选择为自然杀伤细胞的“自我缺失”识别铺平了道路。
Immunogenetics. 2017 Aug;69(8-9):547-556. doi: 10.1007/s00251-017-1011-9. Epub 2017 Jul 11.
10
KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing.KIR3DS1介导的HLA-*B51识别:自身HLA-B同种异型对KIR3DS1反应性的调节及其对自然杀伤细胞许可的影响
Front Immunol. 2017 May 26;8:581. doi: 10.3389/fimmu.2017.00581. eCollection 2017.

本文引用的文献

1
To thine own self be true..做真实的自己。
Curr Biol. 1991 Aug;1(4):239-41. doi: 10.1016/0960-9822(91)90069-9.
2
Human natural killer (NK) alloreactivity and its association with the major histocompatibility complex: ancestral haplotypes encode particular NK-defined haplotypes.人类自然杀伤(NK)细胞同种异体反应性及其与主要组织相容性复合体的关联:祖先单倍型编码特定的NK定义单倍型。
J Exp Med. 1993 Sep 1;178(3):1033-9. doi: 10.1084/jem.178.3.1033.
3
P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities.P58分子作为人类自然杀伤(NK)细胞中主要组织相容性复合体(MHC)I类分子的假定受体。抗p58抗体可重建在具有不同特异性的NK克隆中对MHC I类保护细胞的杀伤作用。
J Exp Med. 1993 Aug 1;178(2):597-604. doi: 10.1084/jem.178.2.597.
4
Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells.I类自身分子可保护正常细胞免受自体自然杀伤细胞介导的裂解。
Eur J Immunol. 1994 Apr;24(4):1003-6. doi: 10.1002/eji.1830240434.
5
Human natural killer cells: origin, clonality, specificity, and receptors.人类自然杀伤细胞:起源、克隆性、特异性及受体
Adv Immunol. 1994;55:341-80. doi: 10.1016/s0065-2776(08)60513-1.
6
Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity.直接证明每个人类外周血T细胞的克隆形成潜力。HLA-DR表达和细胞溶解活性的克隆分析。
J Exp Med. 1983 Feb 1;157(2):743-54. doi: 10.1084/jem.157.2.743.
7
NK susceptibility varies inversely with target cell class I HLA antigen expression.自然杀伤细胞(NK)的敏感性与靶细胞I类人类白细胞抗原(HLA)的表达呈负相关。
J Immunol. 1987 Mar 15;138(6):1657-9.
8
Two subsets of human T lymphocytes expressing gamma/delta antigen receptor are identifiable by monoclonal antibodies directed to two distinct molecular forms of the receptor.通过针对该受体两种不同分子形式的单克隆抗体,可以识别出表达γ/δ抗原受体的两类人T淋巴细胞亚群。
J Exp Med. 1988 Aug 1;168(2):491-505. doi: 10.1084/jem.168.2.491.
9
Surface molecules involved in the activation and regulation of T or natural killer lymphocytes in humans.参与人类T淋巴细胞或自然杀伤淋巴细胞激活与调节的表面分子。
Immunol Rev. 1989 Oct;111:145-75. doi: 10.1111/j.1600-065x.1989.tb00545.x.
10
Biology of natural killer cells.自然杀伤细胞生物学
Adv Immunol. 1989;47:187-376. doi: 10.1016/s0065-2776(08)60664-1.